Teachers Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $5.75M | Buy |
73,296
+3,881
| +6% | +$304K | 0.01% | 1324 |
|
2018
Q4 | $5.88M | Buy |
69,415
+1,741
| +3% | +$147K | 0.01% | 1209 |
|
2018
Q3 | $11.6M | Buy |
67,674
+1,602
| +2% | +$274K | 0.01% | 1013 |
|
2018
Q2 | $8.54M | Buy |
66,072
+5,652
| +9% | +$730K | 0.01% | 1154 |
|
2018
Q1 | $6.23M | Buy |
60,420
+503
| +0.8% | +$51.8K | 0.01% | 1224 |
|
2017
Q4 | $5.12M | Buy |
59,917
+489
| +0.8% | +$41.8K | 0.01% | 1335 |
|
2017
Q3 | $5.05M | Buy |
59,428
+64
| +0.1% | +$5.44K | 0.01% | 1325 |
|
2017
Q2 | $4.5M | Buy |
59,364
+6,746
| +13% | +$511K | 0.01% | 1373 |
|
2017
Q1 | $3.47M | Buy |
52,618
+2,656
| +5% | +$175K | 0.01% | 1489 |
|
2016
Q4 | $3.17M | Sell |
49,962
-183,893
| -79% | -$11.7M | 0.01% | 1527 |
|
2016
Q3 | $14.9M | Buy |
233,855
+68,719
| +42% | +$4.38M | 0.02% | 746 |
|
2016
Q2 | $12.3M | Buy |
165,136
+3,847
| +2% | +$286K | 0.02% | 781 |
|
2016
Q1 | $10.8M | Buy |
161,289
+120,066
| +291% | +$8.02M | 0.02% | 833 |
|
2015
Q4 | $2.79M | Buy |
41,223
+694
| +2% | +$46.9K | 0.01% | 1400 |
|
2015
Q3 | $2.17M | Sell |
40,529
-872
| -2% | -$46.6K | ﹤0.01% | 1531 |
|
2015
Q2 | $2.61M | Sell |
41,401
-5,350
| -11% | -$337K | ﹤0.01% | 1517 |
|
2015
Q1 | $2.25M | Hold |
46,751
| – | – | ﹤0.01% | 1580 |
|
2014
Q4 | $1.55M | Hold |
46,751
| – | – | ﹤0.01% | 1784 |
|
2014
Q3 | $1.37M | Sell |
46,751
-263,686
| -85% | -$7.73M | ﹤0.01% | 1829 |
|
2014
Q2 | $12.1M | Buy |
310,437
+59,508
| +24% | +$2.31M | 0.02% | 789 |
|
2014
Q1 | $10.5M | Buy |
250,929
+82,867
| +49% | +$3.48M | 0.02% | 794 |
|
2013
Q4 | $5.52M | Buy |
168,062
+129,048
| +331% | +$4.23M | 0.01% | 1045 |
|
2013
Q3 | $1.05M | Buy |
39,014
+933
| +2% | +$25.2K | ﹤0.01% | 1895 |
|
2013
Q2 | $889K | Buy |
+38,081
| New | +$889K | ﹤0.01% | 1923 |
|